Skip to content
Cardiovascular healthRandomised trial4 min read

Supervised walking for 9 months lowered systolic pressure by 8.68 mm Hg in hypertension

MoveVitals Editorial Collective · Study published · Reading updated

Original paper:Physical activity, cardiovascular health, quality of life and blood pressure control in hypertensive subjects: randomized clinical trial. · Health and quality of life outcomes · 2018 · Original paper ↗

Key takeaway

In a randomised trial of 207 people with hypertension (68.2 years, 76.8% women), a 9-month supervised walking programme of 120 min/week lowered systolic blood pressure by 8.68 mm Hg and cardiovascular risk score by 1.19 points in multivariate models. The trial was registered retrospectively and the abstract gives no confidence intervals, so the precision of the effect is unknown.

Study design

Randomised trial

Reading basis

Published abstract

Reading focus

Comparator & uncertainty

The research question

Physical activity supports cardiovascular health and health-related quality of life, but its effect on blood pressure control in people who already have hypertension has rarely been studied. The authors tested whether a structured physical activity programme changes cardiovascular risk, quality of life and blood pressure control in hypertensive adults.

Who and how

Randomised clinical trial of a 9-month physical activity programme: a supervised walking group of 120 min/week combined with socio-cultural activities, in 207 hypertensive primary care users (68.2 years, 76.8% women). Physical activity (IPAQ-s questionnaire), diet, cardiovascular disease (CVD) risk, blood pressure, BMI, smoking and health-related quality of life (HRQoL, measured with the SF-36) were assessed at baseline and at the end of the programme. Changes in CVD risk and HRQoL were calculated as end score minus baseline score, and multivariate models were applied. The abstract does not describe what the comparison group did.

What it found

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    In multivariate models, the programme, with no change to diet, lowered the CVD risk score by 1.19 points and systolic blood pressure by 8.68 mm Hg.
  2. 2
    Some areas of quality of life improved, by 4.45 to 14.62 points.
  3. 3
    The programme itself was linked to a higher share of people with controlled blood pressure (OR 5.395 to 5.785, depending on the multivariate model).
  4. 4
    Decreases in CVD risk during the programme (OR 0.609) and increases in the SF-36 physical component summary (OR 1.041), role physical (OR 1.010) and bodily pain (OR 1.014) scores were each also linked to controlled blood pressure, independent of whether pressure was controlled at baseline.

Limits & uncertainty

  1. 1
    The trial was registered retrospectively (5 May 2016), so planned outcomes could not be checked against a registration made in advance.
  2. 2
    The abstract does not say how people were allocated or what the comparison group did, and it reports no confidence intervals or P values, so the precision of the effects is unclear.
  3. 3
    The walking group was supervised and included socio-cultural activities, so any benefit may come from the whole package rather than walking alone; participants were mostly women aged 68.2 years.
  4. 4
    Outcomes were measured only at baseline and at the end of 9 months, so the abstract cannot show whether benefits last. This reading is based on the abstract only.

What to take from it

A supervised group walking routine of 120 min/week over 9 months was followed by lower systolic pressure and better quality-of-life scores in people with hypertension. Because the abstract lacks confidence intervals and a described comparison group, treat 8.68 mm Hg as what happened in this trial, not what you will get. Anyone with hypertension should check an exercise plan with their clinician first.

Reading your own data

A home blood pressure cuff and a step counter or watch can mirror this trial. Log your weekly walking minutes against the 120 min/week target, and compare weekly average blood pressure (seated, rested, same time of day) over several months rather than single readings. Share the trend with your clinician, who decides whether any treatment needs adjusting.

How to read this evidence

Randomisation can support causal inference, but check allocation, blinding, missing outcomes, follow-up and the actual comparator. A trial label alone does not establish high certainty.

Authors’ structured abstract English

The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.

Background

Physical activity (PA) promotes cardiovascular health and health related quality of life (HRQoL), although the effect of that on blood pressure (BP) control has rarely been studied in hypertensive subjects. Our aim was to evaluate the effectiveness of a PA intervention programme on cardiovascular disease (CVD) risk, HRQoL and BP control in hypertensive subjects.

Methods

A randomized clinical trial, with a PA intervention programme of 9 months duration, comprising a walking group of 120 min/week, supervised, and with socio-cultural activities. Participants were 207 hypertensive subjects (68.2 years, 76.8% women). PA (IPAQ-s), diet, CVD risk, BP, BMI, smoking, and HRQoL (SF-36) were assessed at baseline and at the end of the intervention. Changes in CVD risk and in HRQoL during the intervention was calculated (end-baseline score). Multivariate models were applied.

Results

In multivariate models, the PA intervention programme, with no modification of the diet, decreased CVD risk (- 1.19 points) and the systolic BP (- 8.68 mmHg), and increased some areas of HRQoL (4.45 to 14.62 points). An increase in the percentage of subjects with controlled BP was observed by the PA programme itself (OR 5.395 to 5.785 according to multivariate models), and by the changes during the intervention in the decrease in CVD risk (OR 0.609) and in the increase in the HRQoL in physical component summary (OR 1.041), role physical (OR 1.010), and bodily pain (OR 1.014), independently of controlled BP at baseline.

Conclusions

This PA intervention programme improved cardiovascular health and HRQoL, and favoured BP control in primary care users with hypertension.

Trial registration

Clinicaltrials.gov ID NCT02767739 ; Trial registered on May 5th, 2016. Retrospectively registered.

Sources & attribution

Physical activity, cardiovascular health, quality of life and blood pressure control in hypertensive subjects: randomized clinical trial.

Arija V, Villalobos F, Pedret R, Vinuesa A, Jovani D, Pascual G, Basora J.

Health and quality of life outcomes · 2018-09-14

DOI: 10.1186/s12955-018-1008-6 ↗PubMed · 30217193 ↗Europe PMC · Recorded licence: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

MoveVitals editorial interpretation · educational content · no individual clinical review recorded

Sources checked 2026-11-01

Practical guides

Read in context

·Observational meta-analysis

Disrupted daily rest-activity rhythm is linked to higher mortality in 109,365 people

Across seven observational studies with 109,365 participants, a weaker day-night activity contrast (lower relative amplitude) was associated with higher cardiovascular mortality (hazard ratio [HR] 1.50, 95% CI 1.13 to 1.98) and all-cause mortality (HR 1.46, 95% CI 1.27 to 1.68). The evidence base is small and observational, so it cannot show that improving the rhythm lowers risk, and illness may itself disturb the rhythm.

Journal of the American Heart Association

In-depth explainersRead study →
·Trial meta-analysis

Five exercise types lowered resting blood pressure, isometric training the most

Pooling 270 randomised trials with 15,827 participants, aerobic, resistance, combined, interval and isometric training all lowered resting blood pressure compared with non-intervention controls (P<0.001 for each), with the largest fall for isometric training: 8.24 mm Hg systolic and 4.00 mm Hg diastolic. The ranking between modes is partly indirect and the trials differ, so it is not a personal prescription.

British Journal of Sports Medicine

In-depth explainersRead study →
·Randomised trial

A salt substitute lowered stroke, major cardiovascular events and death in rural China

In 20,995 people in 600 rural Chinese villages who had a history of stroke or were 60 or older with high blood pressure, a salt substitute (75% sodium chloride, 25% potassium chloride) lowered the stroke rate versus regular salt over a mean 4.74 years: 29.14 versus 33.65 events per 1000 person-years (rate ratio 0.86, 95% CI 0.77 to 0.96; P = 0.006). Death was also lower (rate ratio 0.88) and serious hyperkalemia events were not significantly higher, but the trial was open-label and set in rural China.

The New England Journal of Medicine

In-depth explainersRead study →
·Validation study/review

Apple Watch irregular-pulse alerts were rare; 34% of those tested had atrial fibrillation

Among 419,297 Apple Watch users with no known atrial fibrillation (AF), 0.52% received an irregular-pulse alert, and 34% of the 450 who returned a usable ECG patch had AF (97.5% CI 29 to 39). Alerts that coincided with patch recording matched AF with a positive predictive value of 0.84 (95% CI 0.76 to 0.92), but only 20.8% of alerted people returned a patch and nobody without an alert was monitored, so a quiet watch does not rule AF out.

The New England Journal of Medicine

In-depth explainersRead study →
Cardiovascular health →